Related by context. All words. (Click for frequent words.) 77 aetiology 74 pathophysiology 72 pathogenesis 68 etiologies 66 pathogenic mechanisms 64 etiologic 64 pathophysiological mechanisms 63 pathophysiologic 63 aetiological 63 underlying pathophysiology 63 pathophysiological 62 endophenotypes 62 multifactorial 62 monoclonal gammopathy 62 molecular mechanisms underlying 61 sonographic appearance 61 etiologic agent 61 syndromes 61 genetic determinants 61 neoplasm 60 chronicity 60 prognostic significance 60 neoplastic 60 etiological 60 etiologic factors 59 clinicopathological 59 causative agent 59 osteochondroma 59 subclinical 59 genetic locus 59 familial aggregation 59 alexithymia 59 viral etiology 59 syndromal 59 nosology 59 pathogenetic 59 pathogenetic mechanisms 59 causal pathway 59 androgen deficiency 58 MGUS 58 Idiopathic 58 thyroid nodules 58 differential diagnosis 58 somatoform disorders 58 pericardial effusion 58 predisposing factors 58 idiopathic 58 potentially modifiable 58 paraneoplastic 58 susceptibility genes 58 genetic loci 58 familial clustering 58 myopathies 58 coagulopathy 58 clinicopathologic 58 genetic polymorphisms 57 radiographic findings 57 granulomatous 57 thyroid dysfunction 57 underdiagnosis 57 pathologic 57 symptomatology 57 monogenic 57 coinfection 57 gastric adenocarcinoma 57 underlying molecular mechanisms 57 preoperative diagnosis 57 Genetic predisposition 57 vasculopathy 57 SSc 57 phenotype 57 phenotypic expression 57 inherited predisposition 57 prognostic markers 57 sonographic findings 57 pathophysiologic mechanisms 57 gastric carcinoma 57 leiomyomas 57 predisposing factor 56 polyarticular 56 primary aldosteronism 56 biopsychosocial 56 hamartomas 56 cystic lesions 56 lymphocytic 56 cryptogenic 56 clinically heterogeneous 56 psychogenic 56 autosomal dominant disorder 56 heritability 56 subclinical hypothyroidism 56 pyelonephritis 56 carcinoid tumor 56 Chlamydia pneumoniae 56 Sjögren syndrome 56 motor neuron degeneration 56 neuroanatomical 56 acetabular dysplasia 56 comorbid disorders 56 prostate cancer CaP 56 metaplasia 56 subsyndromal 56 Bacterial vaginosis 56 genetic susceptibility 56 neoplasms 56 pathophysiologic mechanism 56 subtypes 56 authors conclude 56 urothelial carcinoma 56 proximal colon 56 ANCA associated 56 physiologic mechanisms 56 Genetic variants 55 hereditary predisposition 55 autonomic dysfunction 55 missense mutations 55 LUTS 55 comorbidity 55 adnexal mass 55 urolithiasis 55 Kraepelin 55 neurodevelopmental disorder 55 genetic underpinnings 55 syndromic 55 penetrance 55 pain syndromes 55 neuropsychological impairment 55 fibrocystic 55 epididymitis 55 prostate carcinogenesis 55 urethritis 55 orchitis 55 calculi 55 microvascular disease 55 antiphospholipid syndrome 55 angiographically 55 demyelinating 55 molecular subtypes 55 differential diagnoses 55 molecular underpinnings 55 genetic heterogeneity 55 multi factorial 55 somatoform disorder 55 mucinous 55 causal pathways 55 laterality 55 fibroma 55 sequelae 55 CTEPH 55 airway hyperresponsiveness 55 neuropsychiatric disorders 55 hydronephrosis 55 radiculopathy 55 H pylori 55 metabolic abnormalities 55 neuronal dysfunction 55 polygenic 55 nongenetic 55 diabetes mellitus 55 physiological mechanisms 55 neurobiological 55 aneurysmal bone cyst 55 primary hyperparathyroidism 55 rhinosinusitis 55 neuropathologic 55 chorioamnionitis 55 transcriptional regulation 55 POAG 55 morphologic 55 Trichophyton rubrum 55 microbiota 55 causative agents 55 neoplastic lesions 54 hepatocellular carcinoma 54 pulmonary metastases 54 NAFLD 54 comorbid depression 54 oncogenesis 54 diabetes mellitus DM 54 hyperplastic 54 VUR 54 APOE genotype 54 renal scarring 54 hematuria 54 cerebral infarction 54 microdeletion 54 MYH9 54 lipoprotein metabolism 54 ADPKD 54 immunodeficiencies 54 Lyme arthritis 54 hypochondriasis 54 CD1d 54 nonalcoholic steatohepatitis 54 neurological manifestations 54 sonographic diagnosis 54 prognostic indicator 54 neuropsychiatric diseases 54 somatization disorder 54 incompletely understood 54 posttraumatic 54 somatic symptoms 54 CP CPPS 54 functional polymorphism 54 LRRK2 mutations 54 hyperalgesia 54 syndrome OSAS 54 epilepsies 54 prognostic indicators 54 Cognitive impairment 54 neurological abnormalities 54 comorbid anxiety 54 varicocele 54 subtype 54 chromosome #p#.# 54 modifiable risk 54 prostatitis 54 biologic plausibility 54 pyoderma 54 susceptibility loci 54 biochemical markers 54 mediastinitis 54 Helicobacter pylori infection 54 epidemiologic 54 Etiology 54 myocardial dysfunction 54 histologic subtype 54 tricuspid regurgitation 54 myeloproliferative disorders 54 causative 54 BERKELEY CA UroToday.com 54 myeloproliferative diseases 54 neuropsychiatric disorder 54 genetic aberrations 54 thromboembolic disease 54 DNA methylation patterns 54 esophageal squamous cell carcinoma 54 tumor histology 53 comorbid psychiatric disorders 53 prognostic factor 53 noncardiac 53 Venous thromboembolism 53 comorbidities 53 Chronic pancreatitis 53 cholestasis 53 genetic polymorphism 53 autosomal dominant 53 reflux esophagitis 53 congenital anomalies 53 osteochondromas 53 pituitary adenomas 53 Sydenham chorea 53 histopathological 53 rheumatic diseases 53 FTLD 53 psychiatric comorbidity 53 neoplasias 53 untreated celiac disease 53 mitochondrial dysfunction 53 molecular pathogenesis 53 incidentalomas 53 diathesis 53 IgA deficiency 53 premalignant 53 cerebellar vermis 53 maculopathy 53 immunocompetent 53 metabolic abnormality 53 residual confounding 53 adenomatous 53 delayed gastric emptying 53 choroidal neovascularization 53 histologic 53 gene polymorphisms 53 hypercalciuria 53 #q#.# deletion syndrome 53 atherogenesis 53 atherothrombotic 53 supratentorial 53 C. trachomatis 53 multisystem disease 53 Accurately identifying 53 Periodontitis 53 hypoxemia 53 atherothrombotic disease 53 mGluR5 inhibition 53 congenital adrenal hyperplasia 53 confounder 53 genetic predisposition 53 disc degeneration 53 thromboembolic complications 53 origin PNH 53 unknown etiology 53 lymphadenopathy 53 intracranial hypertension 53 adrenalectomy 53 atopic 53 logistic regression model 53 virulence genes 53 epigenetic modification 53 IPAH 53 leiomyoma 53 gastro oesophageal reflux disease 53 cervicitis 53 germline mutations 53 Zollinger Ellison syndrome 53 sporadic ALS 53 osteoid osteoma 53 paraganglioma 53 Diabetes mellitus 53 hyperparathyroidism 53 neural correlates 53 etiological factors 53 pathophysiological processes 53 mesotheliomas 53 #q#.# [002] 53 LVNC 53 gastric carcinogenesis 53 susceptibility gene 53 arthropathy 53 pharmacological approaches 53 glomerulonephritis 53 methylation patterns 53 essential thrombocythemia 53 extramedullary 53 erythema nodosum 53 Genetic variation 53 malperfusion 53 neuropathological 53 pathologic diagnosis 53 aortic regurgitation 53 Intussusception 53 hyperinsulinemia 53 psychopathology 53 hepatic cirrhosis 53 IDH mutations 53 exfoliative glaucoma 53 Endothelial dysfunction 53 polyposis 53 IntroductionThe 53 susceptibility locus 53 renal fibrosis 53 FGFR2 gene 53 recurrent laryngeal nerve 52 valvular heart 52 channelopathies 52 diabetes dyslipidemia 52 eccrine 52 Irritable bowel syndrome 52 thromboembolic 52 pheochromocytoma 52 haematuria 52 underlying vasculopathy 52 aberrant activation 52 differential gene expression 52 simplex virus 52 affective disorders 52 prognostic marker 52 giant cell arteritis 52 dissecans 52 hyperhomocysteinemia 52 etiological agent 52 microvascular dysfunction 52 idiopathic pulmonary 52 ccRCC 52 sequela 52 recurrent miscarriage 52 SLC#A# [002] 52 extracranial 52 thyroiditis 52 phenotypic variation 52 cholelithiasis 52 metabolic dysfunction 52 dyslipidaemia 52 folate deficiency 52 gastro oesophageal reflux 52 paragangliomas 52 sacral neuromodulation 52 nonalcoholic steatohepatitis NASH 52 subclinical atherosclerosis 52 superior mesenteric artery 52 ALI ARDS 52 carcinoid 52 juvenile idiopathic arthritis 52 #F FDG PET 52 carcinoids 52 highly heritable 52 Psychiatric disorders 52 systemic inflammation 52 FDG uptake 52 proteoglycan 52 airway remodeling 52 cerebral vasospasm 52 myocardial ischemia 52 N glycan 52 prognostic variables 52 Prenatal diagnosis 52 mycosis fungoides 52 neuropsychological functioning 52 lacunar 52 necrotizing 52 familial predisposition 52 SIADH 52 rheumatic disorders 52 vesicoureteral reflux 52 phenotypes 52 postoperative radiotherapy 52 neuroinflammation 52 lymphocyte activation 52 multi factorial disease 52 fibrosing 52 cardiovascular cerebrovascular 52 epithelioid 52 neuropathies 52 hypoplasia 52 gastroduodenal 52 testicular germ cell 52 dystrophies 52 HeFH 52 ataxias 52 fulminant hepatic failure 52 PCNSL 52 monozygotic twins 52 primary biliary cirrhosis 52 parenchymal 52 gastric cardia 52 Takayasu arteritis 52 antiphospholipid antibodies 52 Hashimoto thyroiditis 52 efferent 52 enterocolitis 52 chlamydial 52 myofascial pain syndrome 52 breast carcinoma 52 hyperinsulinism 52 arterial hypertension 52 liver fibrosis 52 Genetic variations 52 #q#.# [001] 52 nephrogenic 52 aberrant methylation 52 TCF#L# gene 52 myelopathy 52 tuberculous 52 causal 52 morphologic characteristics 52 asplenia 52 genetic susceptibilities 52 paresis 52 hallux limitus 52 HSV1 52 Prognostic factors 52 lichen planus 52 autoimmune thyroid 52 gastro esophageal reflux 52 CagA 52 polymyalgia rheumatica 52 clinico pathological 52 dysuria 52 Hallux valgus 52 PAOD 52 Heritability 52 myeloproliferative neoplasms 52 vascular anomalies 52 meningiomas 52 microbiomes 52 arterial venous 52 nasal polyposis 52 T2DM 52 neurocognitive deficits 52 HLA DRB1 52 rheumatic disease 52 breast cancer subtypes 52 EBV infection 52 gene polymorphism 52 neuropathic 52 chromosomal anomalies 52 HRQOL 52 neuritic 52 hypothalamic pituitary adrenal axis 52 HNSCC 52 affective psychoses 52 GBA mutations 52 chromosomal rearrangement 52 de novo mutations 52 degenerative spondylolisthesis 52 muscular dystrophies 52 comorbid 52 neurochemistry 52 epigenetic regulation 52 insertional 52 ischemic mitral regurgitation 52 OSAHS 52 thyrotropin levels 52 murine model 52 carcinomatosis 52 molecular biomarkers 52 malignant neoplasms 52 somatic complaints 52 subtyping 52 anterograde 52 varicoceles 52 facioscapulohumeral muscular dystrophy 52 EGFR mutation status 52 clefting 52 appendiceal 52 valvular 52 splenic 52 nephrolithiasis 52 genomic variation 52 cervical lymph nodes 52 Mitral regurgitation 52 utero exposure 52 pulvinar 52 parkinsonism 52 talar dome 52 inflammatory bowel disease 52 myeloproliferative 52 dysregulation 52 pathognomonic 52 psychiatric comorbidities 52 myocardial ischaemia 51 autoimmune thyroiditis 51 penile cancers 51 ASCUS 51 Chronic sinusitis 51 epithelia 51 neurogenic bladder 51 immune dysregulation 51 amyloid cascade 51 biochemical mechanisms 51 arthrography 51 psychobiological 51 Patellofemoral 51 biochemical abnormalities 51 proliferative diabetic retinopathy 51 rs# [002] 51 microsatellite instability 51 bile acid metabolism 51 advanced adenoma 51 herpesviruses 51 causative genes 51 hereditary hemochromatosis 51 synovial 51 hamartoma 51 malabsorptive 51 pharmacodynamic biomarkers 51 T1a 51 aortic atherosclerosis 51 molecular determinants 51 susceptibility 51 pharmacological therapies 51 infectious mononucleosis 51 geographic atrophy 51 lymph node metastasis 51 mtDNA mutations 51 ileal 51 Haptoglobin 51 rheumatologic 51 renal tumors 51 neurobiological mechanisms 51 Churg Strauss syndrome 51 karyotypes 51 Androgenetic alopecia 51 hypogonadotropic hypogonadism 51 colorectal cancer CRC 51 endoscopic ultrasonography 51 myoclonus 51 Subclinical 51 Dysregulation 51 OPRM1 51 decompensated cirrhosis 51 vidofludimus 51 sensorineural hearing loss 51 clinicopathological features 51 schwannoma 51 neurocognitive impairment 51 melanocytic 51 euthymic patients 51 morbidity 51 postoperative AF 51 C. pneumoniae 51 HIVAN 51 functional gastrointestinal disorders 51 progressive neurodegenerative disorder 51 spontaneous regression 51 biologies 51 inherited mutations 51 neuroendocrine 51 periodontal diseases 51 histologic findings 51 MYH9 gene 51 mito 51 prodromal 51 CNTNAP2 51 radicular 51 immunological mechanisms 51 mechanistic explanation 51 NOD2 51 spontaneous bacterial peritonitis 51 Atopic dermatitis 51 genomic alterations 51 endotoxemia 51 survivin expression 51 atrophic gastritis 51 Dental caries 51 fibrotic disease 51 Chronic inflammation 51 varus deformity 51 idiopathic scoliosis 51 bacterial prostatitis 51 jugular venous 51 hypoperfusion 51 #p# [001] 51 leaky gut 51 Posttraumatic stress disorder 51 unmeasured confounders 51 #q# deletion 51 anatomic abnormalities 51 nasopharyngeal carcinoma 51 polymicrobial infections 51 denervation 51 idiopathic PAH 51 genes differentially expressed 51 carcinogenesis 51 HRCT 51 polyuria 51 Neovascular AMD 51 subclinical hyperthyroidism 51 HPA axis 51 mediastinal 51 Schizoaffective disorder 51 Sezary syndrome 51 complement inhibitor eculizumab 51 Hurthle cell 51 systemic lupus erythematosus 51 diagnostic modality 51 neurologic symptoms 51 dissociative disorders 51 cytomegalovirus infection 51 allelic variation 51 LPS induced 51 atopic diseases 51 neurodevelopmental disorders 51 Leydig cell 51 neurosyphilis 51 nephropathy 51 intersexuality 51 elevated IOP 51 papillary renal cell carcinoma 51 follicular adenoma 51 extrapulmonary 51 neurobiological underpinnings 51 epigenetic mechanisms 51 Chronic constipation 51 anterior uveitis 51 osteochondrosis 51 pathologies 51 Dysplasia 51 Trichomonas vaginalis 51 herpes zoster shingles 51 generalized epilepsy 51 endocannabinoid signaling 51 antitumor effect 51 atopy 51 demyelinating diseases 51 pretest probability 51 vascular dysfunction 51 von Willebrand disease 51 precursor lesions 51 inflammatory demyelinating 51 macroalbuminuria 51 cardiac fibrosis 51 Major depressive disorder 51 microvascular complications 51 Heavy menstrual bleeding 51 neonatal respiratory distress 51 Vitamin D insufficiency 51 neurogenic 51 genitourinary 51 circadian genes 51 otitis 51 biologic pathways 51 fibrous dysplasia 51 mesenteric 51 psychopathological 51 dominantly inherited 51 cAMP signaling 51 PTEN mutations 51 mosaicism 51 neurologic complications 51 plain radiographs 51 periprocedural MI 51 β1 51 cryptogenic stroke 51 chronic rhinosinusitis 51 Brugada syndrome 51 SLC#A# [001] 51 thyrotoxicosis 51 pre malignant lesions 51 Adjuvant therapy 51 Chronic lymphocytic leukemia 51 thyroid nodule 51 vertebral subluxation 51 univariate analyzes 51 tumorigenicity 51 asymptomatic 51 obstructive coronary artery 51 Inflammatory bowel disease 51 periodontal infection 51 cerebellar 51 AA Amyloidosis 51 morphometry 51 lysosomal storage disease 51 Brugada Syndrome 51 sCJD 51 leukocyte recruitment 51 metastatic bone 51 nonischemic 51 somatization 51 pulmonary metastasis 51 surrogate marker 51 aerodigestive tract 51 polycythemia vera PV 51 olfactory dysfunction 51 microbiologic 51 untreated psychosis 51 impingement syndrome 51 modifier genes 51 unmeasured factors 51 bicuspid aortic valves 51 multicentric 51 Magnesium deficiency 50 artery stenosis 50 immunohistochemical staining 50 neurasthenia 50 generalized seizures 50 Barrett esophagus BE 50 osteomyelitis 50 hydrops 50 skeletal metastases 50 comorbid conditions 50 prevalence 50 Onychomycosis 50 optic atrophy 50 Ischemic 50 hepatic 50 CEACAM1 50 iritis 50 heparin induced thrombocytopenia 50 adrenal hyperplasia 50 dopamine receptor gene 50 diabetic microvascular complications 50 interstitial cystitis 50 sonographic evaluation 50 polymicrobial 50 infective endocarditis 50 Subgroup analyzes 50 hyperuricaemia 50 distant metastasis 50 chronic periodontitis 50 cardiac biomarkers 50 polycythemia vera essential thrombocythemia 50 autosomal dominant inheritance 50 Pelvic inflammatory 50 evolutionarily conserved 50 variceal bleeding 50 carotid atherosclerosis 50 childhood disintegrative disorder 50 pyloric stenosis 50 gallstone disease 50 mediated inhibition 50 prodrome 50 chlamydial infection 50 metabolomic profiles 50 lumbosacral 50 SLNB 50 molecular mechanisms 50 familial polyposis 50 dysglycemia 50 mitochondrial disorders 50 femoral neck fractures 50 neuropsychological impairments 50 immunopathology 50 FDG PET imaging 50 benign positional vertigo 50 bacteriuria 50 virally induced 50 postoperative delirium 50 Pseudomonas aeruginosa infections 50 schwannomas 50 Comorbid 50 polypoid lesions 50 chronic prostatitis 50 urogenital 50 thyroid carcinoma 50 Susceptibility 50 Gastroesophageal reflux disease 50 Nonalcoholic fatty liver 50 allele frequencies 50 ALK mutations 50 hemolytic 50 urethral stricture 50 invasive lobular 50 orthologs 50 developmental abnormalities 50 isotypes 50 acute leukemias 50 Comorbidities 50 Candidiasis 50 JAK mutations 50 epithelial tumors 50 HRQL 50 Psoriatic arthritis 50 connective tissue disorders 50 dysplasias 50 Klinefelter syndrome 50 gonococcal 50 dysautonomia 50 distal femur 50 mitochondrial toxicity 50 temporal arteritis 50 neurologic disorder 50 serum biomarkers 50 immunomodulation 50 autistic enterocolitis 50 femoral neck fracture 50 nerve palsy 50 Subtypes 50 epistasis 50 demyelination 50 morphological 50 oropharyngeal cancer 50 adenomatous polyps 50 liver metastasis 50 schizophreniform disorder 50 COL#A# 50 hallux rigidus 50 ADAM# 50 causative mutation 50 cardioprotective effects 50 perianal 50 Sjogren syndrome 50 myocardial fibrosis 50 inflammatory rheumatic 50 nucleosome positioning 50 choriocarcinoma 50 puerperal psychosis 50 colorectal carcinogenesis 50 heritable variation 50 mRNA expression 50 oropharyngeal 50 overt hypothyroidism 50 atopic asthma 50 pulmonary nodules 50 multisystem disorder 50 herpetic 50 nephron sparing surgery 50 G6PD deficiency 50 causative factors 50 genetic syndromes 50 congenital anomaly 50 prognostic factors 50 poststroke depression 50 distinct subtypes 50 bullous 50 nasal obstruction 50 vermis 50 lymph node enlargement 50 nociception 50 WNK1 50 TIMP 50 pulmonary toxicity 50 Autistic Disorder 50 epiglottitis 50 adjuvant therapies 50 molecular abnormalities 50 Clinical Relevance 50 chest radiography 50 T1DM 50 PCa 50 autistic regression 50 cerebral hemispheres 50 neurofibromas 50 hallux valgus 50 convergent validity 50 chromosomal translocations 50 dietary patterns 50 atopic disorders 50 neurofibroma 50 Idiopathic pulmonary fibrosis 50 hypovitaminosis D 50 coronary stenosis 50 cytoreductive surgery 50 STK# gene 50 membrane proximal 50 thyrotropin 50 PTHrP 50 C. neoformans 50 histologic subtypes 50 ontogeny 50 velo cardio facial 50 invasive carcinoma 50 dysphoric 50 ischemic cardiomyopathy 50 dysfunctional voiding 50 occlusive disease 50 predisposing 50 pharmacological interventions 50 pharmacologic intervention 50 hepatocellular carcinomas 50 heterotaxy 50 hyperoxaluria 50 AAT deficiency 50 pharmacologic treatments 50 transurethral resection 50 multivariate analyzes 50 Lenzenweger 50 spinocerebellar ataxia 50 bronchopulmonary dysplasia BPD 50 arthrosis 50 asthma exacerbations 50 MECP2 gene 50 nodal metastases 50 microscopic colitis 50 Diabetic nephropathy 50 ventricular myocardium 50 dementia praecox 50 adenomyosis 50 gonococcal infections 50 diabetic kidney 50 intestinal metaplasia 50 Chlamydia trachomatis 50 sub syndromal 50 anosognosia 50 pneumonectomy 50 bone scintigraphy 50 nonadherence 50 Sleep disordered breathing 50 PsA 50 postoperative complication 50 histological subtype 50 neuropsychological deficits 50 recurrent DVT 50 pharmacologic approaches 50 medium chain acyl 50 thymoma 50 hypothalamic pituitary 50 emotional dysregulation 50 Raynaud syndrome 50 foci 50 vaginitis 50 #q# [001] 50 LRP5 50 esophagogastric 50 elevated CRP 50 genitourinary tract 50 GISTs 50 glomerular 50 retrovirus XMRV 50 SNP rs# [002] 50 knee osteoarthritis OA 50 serum markers 50 intestinal biopsy 50 mycosis 50 pleiotropic effects 50 histopathologic 50 nonoperative treatment 50 chronic hepatitis cirrhosis 50 causative gene 50 NR#A# 50 progressive dyspnea 50 serologic tests 50 ischemic lesions 50 Helicobacter 50 invasive aspergillosis 50 microscopic hematuria 50 FGFR2 50 morbidities 50 atrophic 50 evolvability 50 lateral radiograph 50 neurologic disorders 50 underdiagnosed 50 membranous nephropathy 50 nonmelanoma skin cancer 50 idiopathic intracranial hypertension 50 arrhythmogenic 50 Chronic bronchitis 50 varicella infection 50 ATTR CM 50 Irritable bowel syndrome IBS 50 causative pathogen 50 BPS IC 50 OBJECTIVES 50 Genetic susceptibility 50 intestinal microbiota 50 astrocytomas 50 chronic relapsing